Effect of cerebrocrast on the lymphocyte blast traasformation activity in normal and streptozotocin-induced diabetic rats

Cell Biochemistry and Function

Volumn 17, Issue 2, 1999, Pages 89-96

  Briede, Janĩna ^a   Daija, Daina ^a   Stivrina, Mãra ^a   Duburs, Gunãrs ^a  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

1,4 dihydropyridine; Blast transformation; Ca antagonist; Cerebrocrast; Rat spleen; Streptozotocin (STZ) induced diabetic rats; Thymus and lymph nodes lymphocytes

Indexed keywords

CEREBROCRAST; CONCANAVALIN A; INSULIN; INSULIN ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; NOOTROPIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BLAST TRANSFORMATION; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; DISEASE COURSE; DNA SYNTHESIS; GLYCOLYSIS; IMMUNE SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; LYMPH NODE; LYMPHOCYTE; LYMPHOCYTE COUNT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SUPPRESSOR CELL; T LYMPHOCYTE; THYMUS;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CONCANAVALIN A; DIABETES MELLITUS, EXPERIMENTAL; DIHYDROPYRIDINES; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; RATS; RATS, INBRED STRAINS; REFERENCE VALUES;

ANIMALIA;

EID: 0033030859     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0844(199906)17:2<89::AID-CBF813>3.0.CO;2-2     Document Type: Article

References (56)

1. Cavender, D., Rabin, B. and Finegold, D. (1984). A new sensitive immunohistochemical assay for islet cell cytoplasm antibodies (ICA). Diabetes, 33(Suppl. 1), 63.
2. Lernmark, A., Freedman, Z. R., Hofman, C., Rubenstein, A. H., Steiner, D. F., Jackson, R. L., Winter, R. J. and Traisman, H. S. (1978). Islet-cell surface antibodies in juvenile diabetes mellitus. N. Engl. J. Med., 299(8), 375-380.
3. Bone, A. J., Shirling, D., Gilchrist, M., Tames, F. J. and Baird, I. D. (1983). Prediabetes in the spontaneously diabetic BB Wastrel rat: islet secretion of insulin and islet cell surface antibodies. Diabetologia, 25, 142.
4. Palmer, J. P., Clemons, P., Lyen, K., Tatpati, O., Raghu, P. K. and Paquette, Th. L. (1983). Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science, 222, 1337-1339.
5. Wilking, T. J., Nicholson, S. and Casey, C. R. (1984). Autoantibodies to human insulin. Diabetologia, 27, 346.
6. Shechter, Y., Elias, D., Maron, R. and Cohen, I. R. (1984). Appearance of insulin-receptor antibodies in mice and man. Diabetologia, 27, 332.
7. Maron, R., Elia, D., de Jongh, B. M., Bruining, G. J., van Rood, J. J., Shechter, Y. and Cohen, I. R. (1983). Autoantibodies to the insulin receptor in juvenile onset insulin-dependent diabetes. Nature, 303, 817.
8. Kull, F. C., Jacobs, J. S., Fu Su, Y., Svoboda, M. E., van Wyk, J. J. and Cuatrecasas, P. (1983). Monoclonal antibodies to receptor for insulin and somatomedium-C. J. Biol. Chem., 258(10), 6561-6566.
9. Kahn, C. R., Baird, K. L., Jarrett, D. B. and Flier, J. S. (1978). Direct demonstration that receptor crosslinking or aggregation is important in insulin action. Proc. Natl. Acad. Sci. U.S.A., 75(9), 4209-4213.
10. Baldwin, D. J., Ferris, S. and Steiner, D. F. (1980). Characterisation of insulin-like actions of anti-insulin receptor antibodies. J. Biol. Chem., 255(9), 4028.
11. Schernthaner, G., Ludwig, H, Mayer W (1976). Genetic factors in insulin antibodies in juvenile-onset diabetes. N. Engl. J. Med., 295, 622.
12. Schernthaner, G., Ludwig, H. and Mayer, W. (1979). Immunoglobulin-G-insulin antibodies and immune region-associated alloantigen in insulin-dependent diabetes mellitus. J. Clin. Endocr. Metab., 48, 403-407.
13. Schernthaner, G. (1989). Is human insulin better than animal insulin in the treatment of insulin-dependent diabetes mellitus. In: Diabetes Mellitus Pathophysiology and Therapy. (Creutzfeldt, W. and Lefebvre, P., eds). Springer-Verlag: Berlin, Heidelberg, New York, London, Paris, Tokyo. XXVII, pp. 234-242.
14. Schernthaner, G., Borkenstein, M., Fink, M. and Mayer, W. (1983). Immunogenicity of human insulin (Novo) or porn, monocomponent insulin in HLA-DR-typed insulin-dependent diabetes individuals. Diabetes Care, 6(Supp. 1), 43.
15. Korsangiya, B. M., Gvasaliya, M. M. and Kirashvilli, R. B. (1989). Immunology of Diabetes mellitus and biostator. Publishing House "Mecniereba" Tbillisy: Georgia, pp. 1-96 (in Russian).
16. Ullrich, A., Dull, T. J., Gray, A., Brosius, J. and Sures, I. (1980). Genetic variation in the human insulin gene. Science, 209, 612-615.
17. Nerup, J., Mandrup-Poulsen, T., Molvig, J., Helqvist, S. and Dall Wogensen, L. (1989). On the pathogenesis of insulin-dependent Diabetes mellitus. A discussion of three recently proposed models. In: Diabetes mellitus Pathophysiology and Therapy. (Creutzfeldt, W. and Lefebvre, P., eds). Springer-Verlag: Berlin, Heidelberg, New York, London, Paris, Tokyo, XXVII, 39-50.
18. Nerup, J. (1994). Molecular mechanism of beta cell destruction in IDDM. Eur. J. Endocr., 130(Suppl. 2), 18.
19. Palmer, J. P. and McCulloch, D. K. (1991). Perspectives in diabetes. Prediction and prevention of IDDM. Diabetes, 40, 943-947.
20. Ziegler, R., Alper, C. A. and Awdeh, Z., et al. (1991). Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first degree relatives of patients with type 1 diabetes. Diabetes, 40, 709-714.
21. Bottazzo, G. and Dean, B. M. (1984). Evidence of the expression of class II (HLA-A, B, C) molecules in pancreatic islets in type I (insulin-dependent) diabetes. Diabetologia, 27, 259.
22. Zuccarini, O., Pozzille, P., DiMario, U., Iavicoli, M., Andreani, D. and Sensi, M. (1983). Cytotoxic/suppressor T cells and soluble immune complex in diabetic patients with micro-angiopathy. Diabetologia, 25, 207.
23. Webb, D. R., Kraig, E. and Devens, B. H. (1994). Suppressor cells and immunity. In: Mechanism of Immune Regulation. (Grandstein, R. D., ed.). Basel: Karger, pp. 146-192.
24. 8 cells in type 1 (insulin-dependent) diabetes. Diabetologia, 27, 276.
25. Sinclair, T. F., Singh, S. P., Ellyin, F., Kilger, K. and Ezdenli, E. Z. (1983). T-helper to T-suppressor lymphocyte absolute numbers in Diabetes mellitus. Diabetes, 32(Suppl. 1), 23.
26. Dupre, I. and Stiller, C. R. (1989). Induction of partial remission and enhancement of Beta-cell function by cyclosporin in type 1 diabetes. In: Diabetes mellitus Pathophysiology and Therapy (Creutzfeldt, W. and Lefebvre, P., eds). Springer-Verlag: Berlin, Heidelberg, New York, London, Paris, Tokyo, XXVII, 321-335.
27. Eisenbarth, G. S., Ziegler, A. G. and Colman, P. A. (1994). Pathogenesis of insulin dependent (type 1) Diabetes mellitus. In: Joslin's Diabetes mellitus. (Kahn, C. R. and Weir, G. C., eds). Lea & Febiger, A. Waverly company, 216-239.
28. Vialettes, B., Mercier, P., Lassmann, V. and Vague, P. (1984). Cold reacting lymphocytotoxin in recent-onset type (insulin-dependent) diabetes. Diabetologia, 27, 343.
29. Charlesworth, I. A., Campbell, L. V., Rumma, I., Peake, P. and Pussell, B. A. (1984). Effect of serum lymphocytoxic activity on immunoregulatory T lymphocytes in type 1 (insulin-dependent) diabetes. Diabetologia, 27, 264.
30. Abstracts of the Meeting of Estonian, Latvian and Lithuanian Pharmacologists. Publishing House "Institute of Organic Synthesis, Latvian Academy of Science": Riga, Latvia, p. 18.
31. Scott, J., Engelhard, V. N. and Benjamin, D. C. (1984). Enhancement of mixed lymphocyte response (MLR) and mitogen stimulation in BB rat lymphocytes by IL-2 (interleukin-2). Diabetes, 33(Suppl. 1), 61.
32. Olefsky, J. M. and Kolterman, O. G. (1981). Mechanism of insulin resistance in obesity and non-insulin-dependent (type II) diabetes. Amer. J. Med., 70, 151-168.
33. Laakso, M. (1994). Mechanism of insulin resistance in NIDDM. Diabetes Rev. Internat., 3(1), 10-12.
34. Moller, D. E. and Flier, J. S. (1991). Insulin resistance: mechanism, syndromes and implication. N. Engl. J. Med., 325, 938-948.
35. Flier, J. S., Kahn, C. R., Roth, J. and Bar, R. S. (1975). Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science, 190, 63-65.
36. Flier, J. S., Kahn, C. R., Jarrett, D. B. and Roth, J. (1976). Characterisation of antibodies to the insulin receptor. J. Clin. Invest., 58(6), 1442-1449.
37. Dubur, GJ. Veveris MM, Weinheimer, G., Bisenieks, E. A., Makarova, V. R., Kimenis, A. A., Uldrikis, J. R., Lukevics, E. J., Dooley, D. and Osswald, H. (1989). Synthesis and selective vasodilating properties of esters of 2,6-dimethy-4-(2-difluoro-methoxyphenyl)-1,4-dihydro-pyridine-3.5-dicarboxylic acid. Arzneim. Forsch./Drug Res., 39(11)(10), 1185-1189.
38. Klusa, V. (1995). Cerebrocrast: neuroprotectant, cognition enhancer. Drug of the Future, 20(2), 135-138.
39. Miller, D. and Dykor, P. (1967). Biology of the Thymus. Publishing House "Mir": Moscow, Russia. 1-12 (in Russian).
40. Komissarenko, I. V. (1984). Impairment of Adrenal Function by Endocrine Diseases. Publishing House "Zdorovje": Kiev, Ukraine, 1-239 (in Russian).
41. Cohen, J. J. and Duke, R. C. (1984). Glucocorticoid activation of a calcium dependent endonuclease in thymocyte leads to cell death. J. Immunol., 132, 38-42.
42. Wyllite, A. H. (1980). Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 284, 555-556.
43. Cupps, T. R., Gerrard, T. L., Falkoff, R. J., Whallen, G. and Fauci, A. S. (1985). Effects of in vitro corticosteroids on B cells activation, proliferation and differentiation. J. Clin. Invent., 75, 754.
44. Gillis, S., Crabtree, G. R. and Smith, K. A. (1979). Glucocorticoid-induced inhibition of T cell growth factor production I. The effect of mitogen-induced lymphocyte proliferation. J. Immunol., 123, 1624.
45. Bourgeois, S. and Gasson, J. C. (1985). Genetic and epigenetic bases of glucocorticoid resistance in lymphoid cell lines. In: Biochemical Actions of Hormones. (Litwack, G., ed.). Academic Press: New York, London, XII, 331-351.
46. Akha, A. A., Willmott, N. J., Brickley, K., Dolphin, A. C., Galione, A. and Hunt, S. V. (1996). Anti-lg-induced calcium influx in rat B lymphocytes mediated by cGMP through a dihydropyridine-sensitive channel. J. Biol. Chem., 271(13), 7297-7300.
47. Egorin, M. J., Felsted, R. L. and Buchur, N. R. (1977). Phytohaemagglutinin isolectin stimulation of glucose utilisation by lymphocytes. Life Sci., 20(2), 351-358.
48. Krug, U., Krug, F. and Cuatrecasas, P. (1972). Emergence of insulin receptors of human lymphocytes during in vitro transformation. Proc. Natl. Acad. Sci. U.S.A., 69(9). 2604-2608.
49. Helderman, J. H. and Strom, T. B. (1978). Specific insulin binding site on T and B lymphocytes as a marker of cell activation. Nature, 274, 62-63.
50. Rodman, H. M. (1984). Deficient interleukinin-2 synthesis in type I diabetes. Diabetes, 33(Suppl. 1), 11.
51. Cuatrecasas, P. and Tell, P. E. (1973). Insulin-like activity of Concavanalin A and wheat germ agglutinin - direct interaction with insulin receptors. Proc. Natl. Acad. Sci. U.S.A., 70(2), 485-489.
52. Smith, J. W., Steiner, A. L., Newberry, W. M. and Parker, C. W. (1971). Cyclic Adenosine 3′,5′-monophosphate in human lymphocytes. Alteration after phytohemagglutinin stimulation. J. Clin. Invest., 50, 432-441.
53. Diamantstein, T. and Ulmer, A. (1975). The antagonistic action of cyclic GMP and cyclic AMP on proliferation of B and T lymphocytes. Immunology, 28, 113-119.
54. 2+ and membrane potential in lymphocytes. Nature, 295, 68-71.
55. van Tits, L. J. H. and Brodde, O. E. (1990). Cyclic AMP antagonizes mitogen-induced accumulation of inositol phosphates in human peripheral mononuclear leucocytes (MNL) in vitro. Arch. Pharmacol., 341(Suppl.), R82.
56. 2+ and glucose on multiplication and functional differentiation of clonal insulin-producing cells (RIM m 5F). Diabetologia, 27, 256.